A61K 49/0471
Perflubron, i.e. perfluoroctylbromide, c8f17br emulsions
Official title: {Perflubron, i.e. perfluoroctylbromide, C8F17Br emulsions}
A61K49/0471 (Perflubron, i.e. perfluoroctylbromide, c8f17br emulsions) appears on 17 US grants and 8 published applications in this corpus.
Search patents in A61K- Granted patents
- 17
- Published applications
- 8
- Assignees
- 8
- Inventors
- 30
- Latest grant
- 29 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Pre-saturation of the liver and subsequent administration of the contrast agent29 Sep 2020US 10,786,583 B2B. Braun Melsungen AG
- Magnetic resonance imaging cell labeling methods and compositions16 May 2017US 9,649,393 B2Carnegie Mellon University
- Blood clot-targeted nanoparticles22 May 2007US 7,220,401 B2Barnes-Jewish Hospital
- Imaging contrast media and methods of use16 Jul 2002US 6,420,436 B1Alliance Pharmaceutical Corp.
- Lipid dispersions and methods of use26 Mar 2002US 6,361,792 B1Alliance Pharmaceutical Corp.
- Pre-Saturation of the Liver and Subsequent Administration of the Contrast Agent11 Aug 2016US 2016/0228582 A1B. Braun Melsungen AG
- Magnetic Resonance Imaging Cell Labeling Methods and Compositions3 Apr 2014US 2014/0093452 A1Carnegie Mellon University
- Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods12 Nov 2009US 2009/0280055 A1Heinrich-Heine-Universitat Dusseldorf
- Methods and formulations for optimal local delivery of cell therapy via minimally invasive procedures17 Jan 2008US 2008/0015546 A1
- Blood clot-targeted nanoparticles30 Aug 2007US 2007/0202040 A1Barnes-Jewish Hospital
Most cited
By later US patents
- Targeted co-polymers for radiographic imaging210US 5,746,998 AThe General Hospital Corporation · 1998
- Percutaneous lymphography using particulate fluorocarbon emulsions165US 5,114,703 AAlliance Pharmaceutical Corp. · 1992
- Fluorocarbon contrast media for use with MRI and radiographic imaging84US 5,496,535 AAlliance Pharmaceutical Corp. · 1996
- Percutaneous lymphography54US 5,496,536 A1996
- Method for detecting abnormal cell masses in animals43US 4,767,610 AThe Regents of the University of California · 1988